HopeStage
Back to all studies
RecruitingNCT06899165

Psilocybin-assisted therapy for intergenerational trauma

About this titleRead the official source — NCT06899165
Medication studyAges 18+United StatesAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: August 28, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Rachel Yehuda
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06899165
Official title
Show the full official title

Processing Intergenerational Trauma With Psilocybin-Assisted Therapy

Recruitment & locations

Currently recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rachel Yehuda.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies